Reducing Immunogenicity by Design: Approaches to Minimize Immunogenicity of Monoclonal Antibodies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Reducing Immunogenicity by Design: Approaches to Minimize Immunogenicity of Monoclonal Antibodies ; volume:38 ; number:2 ; day:23 ; month:1 ; year:2024 ; pages:205-226 ; date:3.2024
BioDrugs ; 38, Heft 2 (23.1.2024), 205-226, 3.2024
- Urheber
-
Harris, Chantal T.
Cohen, Sivan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40259-023-00641-2
- URN
-
urn:nbn:de:101:1-2405101047270.244922989605
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Harris, Chantal T.
- Cohen, Sivan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques
Implications of Immunogenicity Testing for Therapeutic Monoclonal Antibodies: A Quantitative Pharmacology Framework
Impact of a Heat Shock Protein Impurity on the Immunogenicity of Biotherapeutic Monoclonal Antibodies
Safety, Immunogenicity and Interchangeability of Biosimilar Monoclonal Antibodies and Fusion Proteins: A Regulatory Perspective
Reducing organ immunogenicity during ex vivo machine perfusion
Immunogenicity of Biopharmaceuticals
Immunogenicity of autoantigens
Immunogenicity of Extracellular Vesicles
Optogenetic Peripheral Nerve Immunogenicity
Immunogenicity of botulinum toxin
Immunogenicity of botulinum toxins
Population pharmacokinetic modelling and simulation of monoclonal antibodies including the impact of immunogenicity and importance of study and analysis design factors
Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques
Implications of Immunogenicity Testing for Therapeutic Monoclonal Antibodies: A Quantitative Pharmacology Framework
Impact of a Heat Shock Protein Impurity on the Immunogenicity of Biotherapeutic Monoclonal Antibodies
Safety, Immunogenicity and Interchangeability of Biosimilar Monoclonal Antibodies and Fusion Proteins: A Regulatory Perspective
Reducing organ immunogenicity during ex vivo machine perfusion
Immunogenicity of Biopharmaceuticals
Immunogenicity of autoantigens
Immunogenicity of Extracellular Vesicles
Optogenetic Peripheral Nerve Immunogenicity
Immunogenicity of botulinum toxin
Immunogenicity of botulinum toxins
Population pharmacokinetic modelling and simulation of monoclonal antibodies including the impact of immunogenicity and importance of study and analysis design factors
Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques
Implications of Immunogenicity Testing for Therapeutic Monoclonal Antibodies: A Quantitative Pharmacology Framework
Impact of a Heat Shock Protein Impurity on the Immunogenicity of Biotherapeutic Monoclonal Antibodies
Safety, Immunogenicity and Interchangeability of Biosimilar Monoclonal Antibodies and Fusion Proteins: A Regulatory Perspective
Reducing organ immunogenicity during ex vivo machine perfusion
Immunogenicity of Biopharmaceuticals
Immunogenicity of autoantigens
Immunogenicity of Extracellular Vesicles
Optogenetic Peripheral Nerve Immunogenicity
Immunogenicity of botulinum toxin
Immunogenicity of botulinum toxins